These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Infliximab is ineffective against giant cell arteritis and polymyalgia rheumatica]. Krüger K Z Rheumatol; 2007 Oct; 66(6):536-7. PubMed ID: 17849125 [No Abstract] [Full Text] [Related]
25. Polymyalgia rheumatica and temporal arteritis. Allen NB; Studenski SA Med Clin North Am; 1986 Mar; 70(2):369-84. PubMed ID: 3512931 [TBL] [Abstract][Full Text] [Related]
26. Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management. Gonzalez-Gay MA; Garcia-Porrua C; Miranda-Filloy JA; Martin J Drugs Aging; 2006; 23(8):627-49. PubMed ID: 16964987 [TBL] [Abstract][Full Text] [Related]
27. Polymyalgia rheumatica and elderly onset rheumatoid arthritis. Belloli L; Massarotti M; Marasini B J Clin Rheumatol; 2008 Feb; 14(1):59. PubMed ID: 18431108 [No Abstract] [Full Text] [Related]
28. Immunosuppressive therapy in rheumatic disease. Pirofsky B; Bardana EJ Med Clin North Am; 1977 Mar; 61(2):419-37. PubMed ID: 16187 [No Abstract] [Full Text] [Related]
29. [Polymyalgia rheumatica]. Szymański AF Pol Tyg Lek; 1969 Feb; 24(8):288-9. PubMed ID: 4389303 [No Abstract] [Full Text] [Related]
31. Assessment and management of polymyalgia rheumatica in older adults. Kennedy-Malone LM; Enevold GL Geriatr Nurs; 2001; 22(3):152-5; quiz 155. PubMed ID: 11410767 [TBL] [Abstract][Full Text] [Related]
32. Decreased level of suppressor/cytotoxic T cells (OKT8+) in polymyalgia rheumatica and temporal arteritis: relation to disease activity. Elling H; Elling P J Rheumatol; 1985 Apr; 12(2):306-9. PubMed ID: 3162021 [TBL] [Abstract][Full Text] [Related]
33. Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis? van der Veen MJ; Dinant HJ; van Booma-Frankfort C; van Albada-Kuipers GA; Bijlsma JW Ann Rheum Dis; 1996 Apr; 55(4):218-23. PubMed ID: 8733437 [TBL] [Abstract][Full Text] [Related]
34. Therapeutic hazards of phenylbutazone and oxyphenbutazone in polymyalgia rheumatica. Wadman B; Werner I Lancet; 1967 Mar; 1(7490):597-8. PubMed ID: 4163976 [No Abstract] [Full Text] [Related]
35. Diagnosis of polymyalgia rheumatica and giant cell arteritis: a note of caution. Wysenbeek AJ; Leibovici L; Mor F; Atsmon A Isr J Med Sci; 1987 Dec; 23(12):1257-8. PubMed ID: 3126161 [No Abstract] [Full Text] [Related]
36. [Azathioprine in the treatment of temporal arteritis and polymyalgia rheumatica]. Lovschall S Ugeskr Laeger; 1977 Oct; 139(44):2618-20. PubMed ID: 145049 [No Abstract] [Full Text] [Related]
37. [Polymyalgia rheumatica, a Pandora's box?]. Janssen M; Rasker JJ; Festen JJ; Hulst SG Ned Tijdschr Geneeskd; 1981 Apr; 125(15):575-82. PubMed ID: 6113553 [No Abstract] [Full Text] [Related]
38. [RS3PE syndrome: report of 11 cases]. Bruscas Izu C; Medrano San Ildefonso M; Simon L An Med Interna; 2000 Sep; 17(9):485-7. PubMed ID: 11100535 [TBL] [Abstract][Full Text] [Related]
39. Rheumatology: 11. Evaluation of the patient with pain all over. Puttick MP CMAJ; 2001 Jan; 164(2):223-7. PubMed ID: 11332320 [No Abstract] [Full Text] [Related]
40. Polymyalgia rheumatica and giant cell arteritis: how best to approach these related diseases. Freeman AC; Rapoport RJ J Fam Pract; 2013 Jun; 62(6 Suppl):S5-9. PubMed ID: 23828809 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]